ClinicalTrials.Veeva

Menu

Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer

Stanford University logo

Stanford University

Status

Enrolling

Conditions

Head and Neck Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT00230308
ENT0008 (Other Identifier)
76537 (Other Identifier)
IRB-11402
11402 (Other Identifier)

Details and patient eligibility

About

Through this study, we hope to learn more about the mechanisms, which may contribute to development and progression of head and neck cancer. The long-term goal of this study will be to develop new strategies and drugs for the diagnosis and treatment of head and neck cancer.

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

All patients undergoing surgery at Stanford University for head and neck cancer.

Exclusion criteria

Non-Stanford patients.

Trial contacts and locations

1

Loading...

Central trial contact

Nikita Bedi

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems